CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Epizyme, Inc. (EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for cancer patients, today reported business highlights and operating and financial results for the third quarter of 2015.
Help employers find you! Check out all the jobs and post your resume.
